Catalyst

Slingshot members are tracking this event:

Top line Phase 3 results for OTO-104 in Meniere's disease anticipated

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
OTIC

66%

Additional Information

Additional Relevant Details Clinical trials.gov record in source
https://www.clinical...